Using analytics and bioassays to de-risk your mRNA LNP drug development programme
Pharmaceutical Technology
FEBRUARY 15, 2023
Existing compositions have proven effective but a complex landscape of intellectual property (IP) and licensing agreements make accessing these compositions complex for new parties when attempting to get to the clinic. The bioassays are the canary in the coal mine of how well your process development is going. Where is your payload?
130 
Let's personalize your content